Back

Identification of the 216kbp gene cluster and structure elucidation of gargantulides B and C, new complex 52-membered macrolides from Amycolatopsis sp.

Carretero-Molina, D.; Ortiz-Lopez, F. J.; Gren, T.; Oves-Costales, D.; Martin, J.; Roman-Hurtado, F.; Jorgensen, T. S.; de la Cruz, M.; Diaz, C.; Vicente, F.; Blin, K.; Reyes, F.; Weber, T.; Genilloud, O.

2021-08-11 microbiology
10.1101/2021.08.11.455926 bioRxiv
Show abstract

Gargantulides B and C, two new and highly complex 52-membered glycosylated macrolactones, were isolated from Amycolatopsis sp. strain CA-230715 during an antibacterial screening campaign. The structures of these giant macrolides were elucidated by 2D NMR spectroscopy and shown to be related to gargantulide A, although containing additional {beta}-glucopyranose and/or -arabinofuranose monosaccharides separately attached to their backbones. Genome sequencing allowed the identification of a strikingly large 216 kbp biosynthetic gene cluster, among the largest type I PKS clusters described so far, and the proposal of a biosynthetic pathway for gargantulides A-C. Additionally, genes putatively responsible for the biosynthesis of the amino sugar {beta}-3,6-deoxy-3-methylamino glucose, reported exclusively in gargantulide macrolides, were also found in the cluster and described in this work. The absolute configurations of gargantulides B and C were assigned based on a combination of NMR and bioinformatics analysis of ketoreductase and enoylreductase domains within the multimodular type I PKS. Furthermore, the absolute stereochemistry of the related macrolide gargantulide A has now been revised and completed. Gargantulides B and C display potent antibacterial activity against a set of drug-resistant Gram-positive bacteria and moderate activity against the clinically relevant Gram-negative pathogen Acinetobacter baumannii.

Matching journals

The top 12 journals account for 50% of the predicted probability mass.

1
Journal of Natural Products
11 papers in training set
Top 0.1%
8.1%
2
Nature Communications
4913 papers in training set
Top 26%
6.7%
3
Antimicrobial Agents and Chemotherapy
167 papers in training set
Top 0.4%
6.3%
4
Scientific Reports
3102 papers in training set
Top 32%
3.9%
5
mBio
750 papers in training set
Top 4%
3.9%
6
Journal of Medicinal Chemistry
68 papers in training set
Top 0.3%
3.6%
7
Molecules
37 papers in training set
Top 0.3%
3.6%
8
Frontiers in Microbiology
375 papers in training set
Top 3%
3.6%
9
eLife
5422 papers in training set
Top 26%
3.6%
10
Chemistry – A European Journal
13 papers in training set
Top 0.1%
3.0%
11
ACS Chemical Biology
150 papers in training set
Top 0.5%
3.0%
12
ACS Medicinal Chemistry Letters
16 papers in training set
Top 0.2%
3.0%
50% of probability mass above
13
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.3%
1.9%
14
ACS Omega
90 papers in training set
Top 1%
1.8%
15
European Journal of Medicinal Chemistry
16 papers in training set
Top 0.1%
1.7%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 33%
1.7%
17
Scientific Data
174 papers in training set
Top 1%
1.7%
18
Journal of the American Chemical Society
199 papers in training set
Top 3%
1.7%
19
Bioorganic & Medicinal Chemistry Letters
10 papers in training set
Top 0.1%
1.7%
20
RSC Advances
18 papers in training set
Top 0.6%
1.6%
21
ChemMedChem
15 papers in training set
Top 0.3%
1.5%
22
Frontiers in Chemistry
14 papers in training set
Top 0.2%
1.2%
23
Angewandte Chemie International Edition
81 papers in training set
Top 3%
1.2%
24
Communications Biology
886 papers in training set
Top 17%
0.9%
25
Microbiology Spectrum
435 papers in training set
Top 4%
0.9%
26
Communications Chemistry
39 papers in training set
Top 0.8%
0.9%
27
PLOS ONE
4510 papers in training set
Top 66%
0.8%
28
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 6%
0.8%
29
ACS Infectious Diseases
74 papers in training set
Top 1%
0.7%
30
Pharmaceuticals
33 papers in training set
Top 2%
0.7%